Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. It is grouped under the following drug class(es): Hypoglycemics and Thiazolidinediones. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Diabiom, Glidipion, Glizofar and Piomed. Its PubChem CID is 60560.
Pioglitazone hydrochloride
| CAS No | 112529-15-4 |
|---|---|
| Molecular Formula | C19H21ClN2O3S |
| Molecular Weight | 392.9 g/mol |
| Synonyms | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity.
The listed CAS number is 112529-15-4.
The listed molecular formula is C19H21ClN2O3S.
The listed molecular weight is 392.9 g/mol.
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride.
The source lists Diabiom, Glidipion, Glizofar and Piomed.